KRAS and malignant colon neoplasm: Two large prospective studies conducted in stage II–III colon cancer (Roth et al, 2010) and in advanced colorectal cancer (Bokemeyer et al, 2009; Van Cutsem et al, 2009) have shown that KRAS mutation is not a prognostic factor.